Literature DB >> 20398960

Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method.

Amit G Pandya1, Linda S Hynan, Rafia Bhore, Fransell Copeland Riley, Ian L Guevara, Pearl Grimes, James J Nordlund, Marta Rendon, Susan Taylor, Ronald W Gottschalk, Nnenna G Agim, Jean-Paul Ortonne.   

Abstract

BACKGROUND: The Melasma Area and Severity Index (MASI), the most commonly used outcome measure for melasma, has not been validated.
OBJECTIVE: We sought to determine the reliability and validity of the MASI.
METHODS: After standardized training, 6 raters independently rated 21 patients with mild to severe melasma once daily over a period of 2 days to determine intrarater and interrater reliability. Validation was performed by comparing the MASI with the melasma severity scale. The darkness component of the MASI was validated by comparing it with the difference between mexameter scores for affected versus adjacent normal-appearing skin. The area component of the MASI was validated by comparing it with the area of each section of the face determined by computer-based measurement software.
RESULTS: The MASI score showed good reliability within and between raters and was found to be valid when compared with the melasma severity scale, mexameter scores, and area measurements. Homogeneity assessment by raters showed the least agreement and can be removed from the MASI score without any loss of reliability. LIMITATIONS: Patients were limited to Hispanic, African, and Asian backgrounds.
CONCLUSION: The MASI is a reliable measure of melasma severity. Area of involvement and darkness are sufficient for accurate measurement of the severity of melasma and homogeneity can be eliminated.
Copyright © 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20398960     DOI: 10.1016/j.jaad.2009.10.051

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  30 in total

1.  Clinical efficacy of self-designed Xiaoban Huoxue Prescription on chloasma derived from liver stagnation and blood stasis.

Authors:  Ge Su; Xun Zhou
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Efficacy and Safety of Using Noninsulated Microneedle Radiofrequency Alone Versus in Combination with Polynucleotides for the Treatment of Melasma: A Pilot Study.

Authors:  Ma Christina B Gulfan; Rungsima Wanitphakdeedecha; Supisara Wongdama; Nuttagarn Jantanapornchai; Chadakan Yan; Sarawalai Rakchart
Journal:  Dermatol Ther (Heidelb)       Date:  2022-05-11

3.  A split-face comparison of fractional erbium: YAG laser plus Kligman's formula vs. Kligman's formula monotherapy for facial melasma.

Authors:  Maryam Nasimi; Maryam Ghiasi; Vahideh Lajevardi; Fatemeh Nasiri; Safoura Shakoei
Journal:  Arch Dermatol Res       Date:  2021-10-27       Impact factor: 3.033

4.  Efficacy of 694-nm fractional Q-switched ruby laser (QSRL) combined with sonophoresis on levorotatory vitamin C for treatment of melasma in Chinese patients.

Authors:  H L Zhou; B Hu; C Zhang
Journal:  Lasers Med Sci       Date:  2016-04-28       Impact factor: 3.161

5.  Low-power Fractional Carbon Dioxide Laser Followed by Jessner's Peel versus Jessner's Peel Alone for the Treatment of Melasma.

Authors:  Eman Elmorsy; Nouran Aboukhadr; Maha Tayyeb; Alsayeda A A Taha
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

6.  Double-blind, Placebo-controlled Trial to Evaluate the Effectiveness of Polypodium Leucotomos Extract in the Treatment of Melasma in Asian Skin: A Pilot Study.

Authors:  Chee-Leok Goh; Sai Yee Chuah; Steven Tien; Guan Thng; María Alejandra Vitale; Arancha Delgado-Rubin
Journal:  J Clin Aesthet Dermatol       Date:  2018-03-01

Review 7.  Confetti-like Sparing: A Diagnostic Clinical Feature of Melasma.

Authors:  Douglas C Wu; Richard E Fitzpatrick; Mitchel P Goldman
Journal:  J Clin Aesthet Dermatol       Date:  2016-02

8.  The use of retinoic acid in association with microneedling in the treatment of epidermal melasma: efficacy and oxidative stress parameters.

Authors:  Clarissa L M da Silva Bergmann; Daniela Pochmann; Julio Bergmann; Fernanda Brasil Bocca; Isabel Proença; Jessica Marinho; Alexandre Mello; Caroline Dani
Journal:  Arch Dermatol Res       Date:  2020-09-25       Impact factor: 3.017

Review 9.  Melasma: A Condition of Asian Skin.

Authors:  Michelle X Wu; Ruth Antony; Harvey N Mayrovitz
Journal:  Cureus       Date:  2021-04-10

10.  Skin needling to enhance depigmenting serum penetration in the treatment of melasma.

Authors:  G Fabbrocini; V De Vita; N Fardella; F Pastore; M C Annunziata; M C Mauriello; A Monfrecola; N Cameli
Journal:  Plast Surg Int       Date:  2011-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.